Lupin Receives FDA Approvals for Generic Vfend® Tablets

In a filing to NSE on 6th June 2016 at 11:33 hours, Lupin Limited has announced today that its US subsidiary, Gavis Pharmaceuticals LLC., has received final approvals for its Voriconazole®Tablets, 50 mg & 200 mg and Voriconazole® Oral Suspension, 40 mg/mL from the USFDA to market a generic equivalent of PF Prism C.V's Vfend® Tablets, 50 mg & 200 mg and Vfend® Oral Suspension, 40 mg/mL. The Company shall start promoting the product in the United States shortly.

Voriconazole® Tablets, 50 mg & 200 mg and Voriconazole® Oral Suspension, 40 mg/mL are the AB rated generic equivalent of PF Prism C.V's Vfend® Tablets, 50 mg & 200 mg and Vfend®Oral Suspension, 40 mg/mL. It is advisable among patients of 12 years and above in the treatment of fungal infections like Invasive Aspergillosis, Candidemia in Non-neutropenic patients, Esophageal Candidiasis, Serious fungal infections caused by Scedosporium apiospermum and Fusarium spp. including Fusarium solani in patients who are intolerant of or refractory to other therapy.

 

About the Company

Lupin Limited, an innovation led transnational pharmaceutical company, is Headquartered in Mumbai. The Company is in the production and development of a wide range of branded as well as generic formulations, biotechnology products and APIs globally. It is a significant player in the fields of Cardiovascular, Diabetology, Asthma, Pediatric, CNS, GI, Anti-Infective and NSAID space. It holds leadership positions in both the Anti-TB and Cephalosporin segment.

Lupin is the 6th largest as well as the fastest growing top 10 generics player in the United States which includes 5.5 per cent market share by prescriptions and the 3rd largest Indian pharmaceutical company by sales worldwide.

 

Lupin Share Price Performance

Today Lupin Share Price closed at Rs 1,419.35 which is down by 2.42 per cent.

The Share price recorded a 52 week high of Rs 2,129.00 on 6th October 2015 and a 52 week low of Rs 1,280.00 on 29th March 2016.

The next support level for the share is at Rs 1419.55 and the next resistance level is at Rs 1509.90.

Lupin is one of Dynamic Levels recommended Top 500 Shares.

Get more information on Support and Resistance levels of the share at Lupin Share Price History.